Purification and characterization of macrolide 2'-phosphotransferase from a strain of Escherichia coli that is highly resistant to erythromycin.

Antimicrobial Agents and Chemotherapy
K O'HaraM Kono

Abstract

Macrolide 2'-phosphotransferase [MPH(2')] was purified 90-fold from an erythromycin-resistant strain of Escherichia coli, and its enzymatic properties were investigated. MPH(2') is an inducible intracellular enzyme which showed high levels of activity with 14-member-ring macrolides and extremely low levels with 16-member-ring macrolides. The optimum pH for inactivation of oleandomycin was 8.2, and the optimum temperature of the reaction was 40 degrees C. Enzyme activity was lost by heat treatment at 50 degrees C for 1 min. The isoelectric point and molecular weight of the enzyme were 5.3 and 34,000, respectively. Purine nucleotides, such as GTP, ITP, and ATP, were effective as cofactors in the inactivation of macrolides. Iodine, EDTA, or divalent cations inhibited MPH(2') activity.

References

Jun 1, 1978·Antimicrobial Agents and Chemotherapy·T NishiuraM Kono
Apr 1, 1988·Journal of Bacteriology·A Brisson-NoëlP Courvalin
Jan 1, 1989·The Journal of Antibiotics·V P MarshallR A Johnson
Mar 1, 1986·Antimicrobial Agents and Chemotherapy·A AndremontP Courvalin
Nov 1, 1986·Antimicrobial Agents and Chemotherapy·M Arthur, P Courvalin
Feb 1, 1987·The Journal of Antibiotics·P F WileyV P Marshall
Dec 1, 1967·Journal of Bacteriology·H C Neu, J Chou
Dec 1, 1984·The Journal of Antibiotics·P BarthélémyP Courvalin
Jan 1, 1980·Antimicrobial Agents and Chemotherapy·M KonoY Shiomi
May 1, 1962·The Biochemical Journal·R P NOVICK

❮ Previous
Next ❯

Citations

Jan 11, 2005·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Jari Jalava, Harri Marttila
Oct 29, 2009·Emerging Infectious Diseases·Minh Chau Phuc NguyenAnnie Canu
Dec 1, 1989·Antimicrobial Agents and Chemotherapy·M S KuoV P Marshall
Mar 1, 1995·Antimicrobial Agents and Chemotherapy·B Weisblum
Sep 1, 1993·Antimicrobial Agents and Chemotherapy·M SchulmanB Arison
Dec 20, 2000·Antimicrobial Agents and Chemotherapy·B Vester, S Douthwaite
Nov 10, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·B Weisblum
Apr 19, 2017·Structure·Desiree H FongAlbert M Berghuis
Sep 6, 2005·The Journal of Veterinary Medical Science·Hideki KobayashiKoshi Yamamoto
Oct 17, 2001·Pharmacotherapy·D T BeardenK W Garey
Jul 18, 2018·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Sunjukta Ahsan, Sahida Rahman
Nov 26, 1990·FEBS Letters·R E KneuselK D Klöppel
Aug 17, 2016·Cold Spring Harbor Perspectives in Medicine·Corey FyfeJoyce Sutcliffe
Oct 28, 2016·Critical Reviews in Microbiology·Cláudia GomesJoaquim Ruiz
Feb 17, 2007·FEMS Microbiology Letters·Olivier ChesneauPatrice Courvalin
Sep 5, 2018·Frontiers in Microbiology·Tolou GolkarAlbert M Berghuis
Jul 1, 2017·British Journal of Pharmacology·George P Dinos
Aug 17, 2019·New Biotechnology·Ana C ReisPhilippe F X Corvini
Feb 9, 2021·ACS Synthetic Biology·Corwin A MillerMatthew R Bennett
Oct 3, 1999·Antimicrobial Agents and Chemotherapy·L ZarantonelliW M Shafer
Aug 3, 1999·Antimicrobial Agents and Chemotherapy·K TaniguchiT Sawai
Dec 3, 1999·Antimicrobial Agents and Chemotherapy·M C RobertsH Seppala
Feb 11, 2005·Chemical Reviews·Leonard Katz, Gary W Ashley
Jan 26, 2002·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Yoshinori Nakajima
Jan 26, 2002·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Hideto TsujimotoTakeshi Nishino
Oct 1, 1991·Antimicrobial Agents and Chemotherapy·W Yan, D E Taylor
Feb 1, 1992·Antimicrobial Agents and Chemotherapy·E Cundliffe
Mar 17, 2010·Antimicrobial Agents and Chemotherapy·Tushar Shakya, Gerard D Wright
Nov 26, 1997·Journal of Bacteriology·M A Fernández-MorenoF Malpartida
Nov 1, 1996·Antimicrobial Agents and Chemotherapy·J SutcliffeL Wondrack

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.